Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vertex Pharmaceuticals
Biotech
Vertex boosts artillery with $2B-plus Enlaza pact
Enlaza’s War-Lock platform is designed to create “highly specific warheads” that covalently bind to drug targets.
Gabrielle Masson
Sep 2, 2025 10:26am
Altos ascends with new clinical leader—Chutes & Ladders
Aug 8, 2025 8:30am
Vertex drops asset in acute pain after phase 2 fail
Aug 4, 2025 5:34pm
Vertex diabetes islet cell therapy improves blood sugar levels
Jun 23, 2025 4:21am
Vertex consolidates Rhode Island footprint, cuts 125 jobs
Jun 11, 2025 10:38am
Lilly lands next-gen pain asset in $1B SiteOne acquisition
May 27, 2025 11:30am
